Budesonide ER Capsules
Pre-Solicitation Posted
Not the latest version. See the latest solicitation from .
- Solicitation number
- SPE2D2-25-R-0008
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Not on record
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical is planning to issue a national requirements contract for Budesonide ER Capsules, specifically 3MG in 100 count bottles. This will be an unrestricted and fully competitive commercial item acquisition using FAR Part 12 procedures. The contract will establish a national supply source for the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers through DLA and VA prime vendor programs. Potential offerors can expect a firm-fixed price, requirements-type contract with a one-year base period and four one-year option periods. Interested parties are advised to contact Christopher Newman at (445-737-7371) or christopher.newman@dla.mil for any questions, and to set up automated notifications through the DLA Bid Board System (DIBBS) and SAM.gov websites.
The solicitation does not include any specific set-aside designations, indicating full and open competition for all sources. The projected solicitation date is April 2025, though DLA reserves the right to issue the solicitation before or after this date. The contract will utilize NAICS code 325412 for Pharmaceutical Preparation Manufacturing and PSC code 6505 for Drugs and Biologicals. While specific award values are not disclosed, the contract will be structured to meet national requirements with annual usage estimates to be provided in the Schedule of Supplies section of the forthcoming solicitation. The procurement will follow a requirements-type contract model, which allows for flexible ordering based on actual customer demand throughout the potential five-year contract period.
Notice text
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Budesonide ER Capsules. Procurement details follow.
Budesonide ER 3MG in 100 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov/. Interested parties should contact Christopher Newman (445-737-7371) (christopher.newman@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is April of 2025. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Budesonide ER Capsules | Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Methylphenidate ER | Medical Supply Chain | No set-aside | |
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside | |
| Epinephrine Injector | Medical Supply Chain | No set-aside | |
| 6505--Sodium Bicarbonate Injection Vial Restricted to Made in America | National Acquisition Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity